CERUS CORP (CERS) Operating Margin
- Operating margin · 12 months: Value -0.65%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -0.65% | Operating income / revenue. Period ending 2026-06-30. $-1.62M ÷ $249.22M × 100 ≈ -0.65% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -1.62M USD | Operating Income (Loss) |
| Revenue | 249.22M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
| Research and development | (m) | Research and Development Expense |
| Selling, general and administration | 82.26M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-1.62M | $249.22M | (m) | (m) | $82.26M | -0.65% |
| 2026-03-31 | $-3.18M | $244.22M | (m) | (m) | $80.58M | -1.30% |
| 2025-12-31 | $-8.68M | $233.80M | (m) | (m) | $80.91M | -3.71% |
| 2025-09-30 | $-9.49M | (m) | (m) | (m) | $79.42M | (m) |
| 2025-06-30 | $-11.69M | (m) | (m) | (m) | $78.59M | (m) |
| 2025-03-31 | $-12.10M | (m) | (m) | (m) | $76.38M | (m) |
| 2024-12-31 | $-14.22M | $201.32M | (m) | (m) | $75.89M | -7.07% |
| 2024-09-30 | $-11.80M | (m) | (m) | (m) | $73.83M | (m) |
| 2024-06-30 | $-16.08M | (m) | (m) | (m) | $72.20M | (m) |
| 2024-03-31 | $-23.89M | (m) | (m) | (m) | $73.76M | (m) |
| 2023-12-31 | $-30.05M | $186.80M | (m) | (m) | $75.52M | -16.09% |
| 2023-09-30 | $-40.98M | (m) | (m) | (m) | $81.41M | (m) |
| 2023-06-30 | $-43.18M | (m) | (m) | (m) | $85.16M | (m) |
| 2023-03-31 | $-38.38M | (m) | (m) | (m) | $84.15M | (m) |
| 2022-12-31 | $-34.08M | $188.31M | (m) | (m) | $83.33M | -18.10% |
| 2022-09-30 | $-31.09M | (m) | (m) | (m) | $82.18M | (m) |
| 2022-06-30 | $-34.77M | (m) | (m) | (m) | $82.63M | (m) |
| 2022-03-31 | $-42.34M | (m) | (m) | (m) | $82.85M | (m) |
| 2021-12-31 | $-48.94M | $159.52M | (m) | (m) | $81.29M | -30.68% |
| 2021-09-30 | $-56.31M | (m) | $56.18M | (m) | $77.98M | (m) |
| 2021-06-30 | $-59.17M | (m) | $49.55M | (m) | $73.92M | (m) |
| 2021-03-31 | $-59.38M | (m) | $43.93M | (m) | $70.27M | (m) |
| 2020-12-31 | $-58.33M | $114.25M | $41.16M | (m) | $67.02M | -51.06% |
| 2020-09-30 | $-60.40M | (m) | $38.27M | (m) | $65.49M | (m) |
| 2020-06-30 | $-63.38M | (m) | $34.90M | (m) | $65.33M | (m) |
| 2020-03-31 | $-65.56M | (m) | $33.31M | (m) | $65.96M | (m) |
| 2019-12-31 | $-66.23M | $93.77M | $33.42M | (m) | $66.20M | -70.62% |
| 2019-09-30 | $-65.28M | (m) | $32.57M | (m) | $63.87M | (m) |
| 2019-06-30 | $-61.92M | (m) | $33.13M | (m) | $61.70M | (m) |
| 2019-03-31 | $-57.70M | (m) | $32.74M | (m) | $59.40M | (m) |
| 2018-12-31 | $-54.99M | $76.05M | $31.63M | (m) | $56.84M | -72.30% |
| 2018-09-30 | $-50.38M | $68.38M | (m) | (m) | $54.36M | -73.68% |
| 2018-06-30 | $-49.16M | $63.78M | (m) | (m) | $52.63M | -77.08% |
| 2018-03-31 | $-52.79M | (m) | (m) | (m) | $52.34M | (m) |
| 2017-12-31 | $-57.53M | $51.33M | (m) | (m) | $52.41M | -112.09% |
| 2017-09-30 | $-61.78M | (m) | (m) | (m) | $52.35M | (m) |
| 2017-06-30 | $-63.66M | (m) | (m) | (m) | $52.33M | (m) |
| 2017-03-31 | $-64.19M | (m) | (m) | (m) | $50.64M | (m) |
| 2016-12-31 | $-61.45M | $39.27M | (m) | (m) | $48.75M | -156.45% |
| 2016-09-30 | $-61.34M | (m) | (m) | (m) | $47.59M | (m) |
| 2016-06-30 | $-63.26M | (m) | (m) | (m) | $46.36M | (m) |
| 2016-03-31 | $-62.05M | (m) | (m) | (m) | $46.02M | (m) |
| 2015-12-31 | $-61.08M | (m) | (m) | (m) | $45.99M | (m) |
| 2015-09-30 | $-59.01M | (m) | (m) | (m) | $45.40M | (m) |
| 2015-06-30 | $-54.18M | (m) | (m) | (m) | $43.19M | (m) |
| 2015-03-31 | $-49.66M | (m) | (m) | (m) | $41.21M | (m) |
| 2014-12-31 | $-44.50M | $36.42M | (m) | (m) | $37.73M | -122.21% |
| 2014-09-30 | $-39.38M | (m) | (m) | (m) | $34.47M | (m) |
| 2014-06-30 | $-36.45M | (m) | (m) | (m) | $33.47M | (m) |
| 2014-03-31 | $-32.56M | (m) | (m) | (m) | $31.35M | (m) |
| 2013-12-31 | $-28.30M | $39.66M | (m) | (m) | $29.96M | -71.36% |
| 2013-09-30 | $-24.09M | (m) | (m) | (m) | $29.33M | (m) |
| 2013-06-30 | $-20.00M | (m) | (m) | (m) | $27.82M | (m) |
| 2013-03-31 | $-17.69M | (m) | (m) | (m) | $26.55M | (m) |
| 2012-12-31 | $-17.30M | $36.79M | (m) | (m) | $25.66M | -47.03% |
| 2012-09-30 | $-17.04M | $36.68M | (m) | (m) | $24.81M | -46.44% |
| 2012-06-30 | $-15.43M | $37.68M | (m) | (m) | $23.97M | -40.94% |
| 2012-03-31 | $-16.20M | $35.21M | (m) | (m) | $23.49M | -46.01% |
| 2011-12-31 | $-15.92M | $33.04M | (m) | (m) | $23.05M | -48.19% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-15.96M | $23.11M | (m) | (m) | $21.58M | -69.06% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-23.83M | $17.98M | (m) | (m) | $21.87M | -132.54% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B |